Abajar, Irenito T.
HRN: 15-38-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2024
CEFTRIAXONE 1G (VIAL)
01/22/2024
01/29/2024
IV
1g
Q12h
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes